EMVision Medical Devices Ltd (EMV.AX)
ASX · AUD · Healthcare · Medical Devices
A$1.55 (+1.31%) as of
Key statistics
- Market cap
- 143.62M
- Forward P/E
- -9.42
- EPS (TTM)
- -0.0900
- Dividend yield
- 0.00%
- 52-week range
- 1.4550 – 1.9550
- Beta
- 1.10
- Revenue (TTM)
- 8.36M
- Profit margin
- -99.50%
- Analyst target
- A$3.15
- Volume
- 31.59k
About EMVision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Macquarie Park, NSW, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.